Loading decisions…
Loading decisions…
1,253 vetted Board decisions in 2025.
The Board denied several claims for increased ratings and service connection, but granted service connection for prostate cancer.
The Board granted service connection for prostate cancer under the PACT Act due to presumed exposure to burn pits during the Veteran's service in Southwest Asia.
The Board granted service connection for ischemic heart disease, prostate cancer, and bone cancer as due to herbicide exposure under the PACT Act. The claims for the heart disability and prostate cancer prior to August 10, 2022, were remanded.
The Board granted service connection for prostate cancer and residuals, finding that the Veteran's condition was at least as likely as not caused by in-service exposure to contaminated water at Camp Lejeune.
The Board denied an earlier effective date for the award of a total disability rating based on individual unemployability due to service-connected disabilities (TDIU) prior to July 2, 2023.
The Board granted service connection for prostate cancer, finding that the evidence is in approximate balance and supports a nexus between the Veteran's active-duty service and his current condition.
The Board dismissed the veteran's appeal for service connection for PTSD and prostate cancer as an improper attempt to file a Board Appeal request in response to a Board decision.
The Board granted service connection for diabetes mellitus type II, hypertension, hypothyroidism, prostate cancer, sleep apnea secondary to service-connected diabetes mellitus, tinea pedis, and lumbar spondylosis.
The Board denied service connection for colon cancer, skin cancer, and prostate cancer. The Veteran was granted a 20% rating for right knee osteoarthritis status post meniscectomy with instability or subluxation and a 10% rating for a right knee scar.
The Board denied a rating in excess of 50 percent from May 15, 2024, for migraine headaches as the Veteran is already receiving the maximum schedular rating and referral for extraschedular consideration was not warranted.
The Board denied a compensable rating for the Veteran's bilateral hearing loss and remanded the claim for service connection for prostate cancer due to potential toxic exposures.
The Board granted a disability rating of 60 percent for prostate cancer residuals, characterized by urinary incontinence and denied an initial compensable rating for hypertension.
The Board denied the veteran's attempts to appeal rating decisions that denied service connection for various conditions and reduced his evaluation, as the appeals were not timely filed.
The Veteran was granted an earlier effective date of August 10, 2022, for the grant of a total disability rating due to individual unemployability (TDIU).
The Board granted service connection for adjustment disorder with depressed mood and a headache disability, as secondary to the Veteran's service-connected prostate cancer residuals. The Board also granted an increased rating of 60 percent for prostate cancer residuals with voiding dysfunction effective September 29, 2023.
The Board granted an earlier effective date of August 10, 2022 for the grant of service connection for prostate cancer based on the Veteran's ongoing care and evidence that he had prostate cancer as early as 2018.
The Board remands the claims for service connection for enlarged prostate, prostate cancer, and a skin disability due to missing records from the Veteran's Naval Reserve Service and Social Security Administration.
The Board denied the Veteran's claim for service connection for prostate cancer and residuals, finding that there was no evidence to support a causal relationship between his in-service prostatitis and his later diagnosis of prostate cancer.
The Board remands the claim for service connection for prostate cancer to correct a pre-decisional duty-to-assist error related to toxic exposure risk activities (TERA) at Camp Lejeune and other exposures as a Mortarman.
The Board remands the claim for a retrospective VA medical opinion to determine if the Veteran's Parkinson disease, prostate cancer, or OSA are related to his service.
← Back to Prostate cancer overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.